Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of therapeutic antibodies for the treatment of diseases
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Human cytomegalovirus: pathogenesis, prevention, and treatment
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
State-of-the-Art Approaches to Heterologous Expression of Bispecific Antibodies Targeting Solid Tumors
Aleksei K. Misorin, Darya O. Chernyshova, Mikhail S. Karbyshev
Biochemistry (Moscow) (2023) Vol. 88, Iss. 9, pp. 1215-1231
Open Access | Times Cited: 5
An inert tracer: The binding site of a fluorescent dye on the antibody and its effects on Protein A chromatography
Narges Lali, Liana Tsiatsiani, Walter Elffrink, et al.
Journal of Chromatography A (2024) Vol. 1728, pp. 464995-464995
Open Access | Times Cited: 1
Benralizumab: The Immuno-Pharmacological State of the Art
Alessandra Vultaggio, Marco Benci, Laura Bergantini, et al.
(2024)
Open Access | Times Cited: 1
Modeling of cell cultivation for monoclonal antibody production processes considering lactate metabolic shifts
Kozue Okamura, Sara Badr, Yusuke Ichida, et al.
Biotechnology Progress (2024)
Open Access | Times Cited: 1
A simplified non-reduced peptide mapping method with faster and efficient enzymatic digestion for characterization of native disulfide bonds in monoclonal and bispecific antibodies
Liqing Gu, Tiger X. Hu
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 250, pp. 116400-116400
Open Access | Times Cited: 1
FvFold: A model to predict antibody Fv structure using protein language model with residual network and Rosetta minimization
Pasang Sherpa, Kil To Chong, Hilal Tayara
Computers in Biology and Medicine (2024) Vol. 182, pp. 109128-109128
Closed Access | Times Cited: 1
Modular Semisynthetic Approach to Generate T Cell-Dependent Bispecific Constructs from Recombinant IgG1 Antibodies
Irene Shajan, Léa N. C. Rochet, S. Tracey, et al.
Bioconjugate Chemistry (2024)
Open Access | Times Cited: 1
Screening and construction of nanobodies against human CD93 using phage libraries and study of their antiangiogenic effects
Hui Miao, Yiling Wu, Hao Ouyang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
Recent advances of molecular imprinting technology for the separation and recognition of complex biological sample systems
Bao-Xuan Xie, Yang Lyu, Zhen Liu
Chinese Journal of Chromatography (2024) Vol. 42, Iss. 6, pp. 508-523
Open Access | Times Cited: 1
Nanobody-as Versatile Tool Emerging in Autoimmune Diseases
Ling Wang, Ran Luo, Wenkang Zhang, et al.
Smart Materials in Medicine (2024)
Open Access | Times Cited: 1
2D-CEX–FcRn–MS to Study Structure/Function Relation of mAb Charge Variants
Liesa Verscheure, Isabel Vandenheede, Eline De Rore, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 45, pp. 18122-18131
Closed Access | Times Cited: 1
Ab-amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model
Yuwei Zhou, Wenwen Liu, Chun-Mei Luo, et al.
Methods (2024) Vol. 233, pp. 11-18
Closed Access | Times Cited: 1
Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR‐NK Cell Engineering
Zhaokai Zhou, Yifeng Chen, Yuhao Ba, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma
Pierre V. Candelaria, Miguel Nava, Tracy R. Daniels‐Wells, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4533-4533
Open Access | Times Cited: 3
Ultrasensitive Electrochemical Immunosensors Using Nanobodies as Biocompatible Sniffer Tools of Agricultural Contaminants and Human Disease Biomarkers
Rodica Elena Ionescu
Micromachines (2023) Vol. 14, Iss. 8, pp. 1486-1486
Open Access | Times Cited: 2
Novel anti-PTEN C2 domain monoclonal antibodies to analyse the expression and function of PTEN isoform variants
Leire Torices, Caroline E. Nunes‐Xavier, José I. López, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289369-e0289369
Open Access | Times Cited: 2
Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches
Mingyue Li, V. Beaumont, Shahajahan Akbar, et al.
mAbs (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Peptide aptamer based on natural protein ligand for C reactive protein detection
Xi Chen, Lili Cui, Tonggong Liu, et al.
Research Square (Research Square) (2024)
Open Access
An Inert Tracer for Protein a Chromatography: A Minimally Fluorescently Labeled Antibody
Alois Jungbauer, Narges Lali, Liana Tsiatsiani, et al.
(2024)
Closed Access
An Inert Tracer: The Binding Site of a Fluorescent Dye on the Antibody and its Effects on Protein a Chromatography
Narges Lali, Liana Tsiatsiani, Walter Elffrink, et al.
(2024)
Closed Access
A generic anti-drug antibody assay for monoclonal antibody therapeutics with broad dynamic range eliminates the need for titer evaluation in preclinical studies
Hao Li, Alejandro R. Foley, Jeongsup Shim, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 249, pp. 116364-116364
Closed Access
Ultrahigh-throughput discovery of modified aptamers as specific and potent enzyme inhibitors
Claire Husser, Janis Hoetzel, Roger Cubì, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Treatment patterns and factors associated with discontinuation of monoclonal antibodies
Muzoon Matar Saleh Alkaabi, Syed Arman Rabbani, Padma Gm Rao, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability
Fortunato Ferrara, Adeline M. Fanni, André A. Teixeira, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access

Scroll to top